Home Technology GW Pharmaceuticals Keeps Climbing

GW Pharmaceuticals Keeps Climbing

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), IAMGOLD Corp (NYSE:IAG) and Transocean Partners LLC (NYSE:RIGP) are making strides on Wall Street this Wednesday. In the red today are Eclipse Resources Corp (NYSE:ECR), Radius Health Inc (NASDAQ:RDUS) and Voltari Corp (NASDAQ:VLTC).

Sign up for our free daily newsletter

GW Pharmaceuticals Continues to Climb

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) gained +11.37% early in the day on the heels of its earnings report, announced yesterday. The British drugmaker, which develops medications utilizing cannabis extracts, also said this week that its treatments could be used in treating autism. GWPH, a Farallon Capital pick, is up +83.27% year-to-date.


IAMGOLD Corp (NYSE:IAG) climbed +9.53% today thanks to rallying gold prices. Billionaire investors John Paulson and Ray Dalio have positions in the company, the share price of which has increased +27.49% over the past month.

Transocean Partners LLC (NYSE:RIGP) got a +9.35% boost this Wednesday, though it’s still lost -31.64% over the past month. Leon Cooperman initiated a 945,000-share position in the company in Q3.

Eclipse Resources Tumbles on Rating Downgrade

The share price of Eclipse Resources Corp (NYSE:ECR) dipped -8.09% this morning in the wake of a rating downgrade from Morgan Stanley. The oil and gas company has had a rough to on the market in 2014, its price down -68.27% YTD. Billionaire investors Leon Cooperman and Richard Chilton picked up stakes in the company in Q3 – an indicator they may expect things to turn around.

Radius Health Inc (NASDAQ:RDUS) tumbled -7.3% today, though the biotech company is still up +176.53% for the year. This is another solid health care pick for Farallon Capital.

Voltari Corp (NASDAQ:VLTC) fell -6.93% early in the day and is down -65.89% YTD. The mobile marketing firms is one of the stocks dragging down Carl Icahn’s portfolio this year.


Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.


Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.